ED vs TRDA · P/E 18, rev $15.26B vs P/E 12, rev $210.8M
Consolidated Edison Inc (ED) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
ED currently screens at market cap $36.02B and trailing P/E 18.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the ED and TRDA stock pages for the full models.
Not investment advice.